Detalhe da pesquisa
1.
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
Mol Ther
; 29(2): 636-644, 2021 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33010231
2.
Is sphere assay useful for the identification of cancer initiating cells of the ovary?
Int J Gynecol Cancer
; 25(1): 12-7, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25365589
3.
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial.
Front Immunol
; 11: 482, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32528460
4.
Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.
Eur J Cancer
; 64: 167-74, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27428073
5.
Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia.
Hemasphere
; 3(2): e174, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31723815
6.
Modulation of CD6 function through interaction with Galectin-1 and -3.
FEBS Lett
; 588(17): 2805-13, 2014 Aug 25.
Artigo
Inglês
| MEDLINE | ID: mdl-24945728
7.
Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.
PLoS One
; 9(11): e113090, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25402503